Biovail’s original application for an extended-release, once-daily formulation of tramadol hydrochloride, intended for the treatment of moderate and moderately severe pain, was submitted in December 2003. Additional clinical
The results, published in the current issue of General Hospital Psychiatry, also suggest that it may be possible to reduce by as much as 40% the time severely
Aeras, a US non-profit organization and Statens Serum Institut (SSI), a company owned by the Danish government, will form a joint product development team and Aeras will provide
In March 2005, Barr confirmed that Kos had filed a motion in a US District Court seeking to prevent Barr from launching generic versions of Niaspan, a cholesterol-lowering
As a result of its scheduled interim safety analysis, the independent data monitoring committee (DMC) recommended the continuation of the clinical trial, named GENASIS, which is designed to
The collaboration aims to develop improved interferon alpha protein therapeutics to treat hepatitis C virus (HCV) and hepatitis B virus (HBV) infections. Maxygen and Roche are currently completing
Under the collaboration, Daiichi will utilize Cyntellect’s high-throughput cell imaging and laser-based cell manipulation technology, LEAP, for novel drug discovery. Cyntellect will design, configure and run LEAP cell-based
The job cuts are part of a restructuring plan the company is implementing in order to reduce its costs. Around 60 jobs will be axed, leaving a workforce
The agreement, which was signed in August last year, granted Pfizer an option to acquire an exclusive worldwide license, covering proprietary NicOx nitric oxide-donating compounds. The compounds are
Advancis’ adult and adolescent pivotal program began on October 15, 2004. Over the coming weeks, patients will complete their treatment and follow-up visits, and Advancis and its clinical
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.